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Abstract 
Background and Aim: Combination therapy is one of the new strategies that minimize resistance to chemotherapy and 
reduces drug toxicity. Here, we investigated the effect of combination therapy with 5-Fluorouracil and Gamma 
Tocopherol on cell survival and BAX/BCL2 gene expression ratio in HT29 colon cancer cells. 
Methods: The proliferation of cancer cells was determined via colony formation assay. 
BAX/BCL2 ratio was evaluated after incubation with concentrations of 5-Fluorouracil and Gamma Tocopherol via 
real-time-PCR. 
Results: The average number of colonies in the cells treated with 5-Fluorouracil, Gamma Tocopherol and their 
combination of them was 63±4, 78±3, and 28±2, respectively which significantly decreased in the combination group. 
In contrast with the control group, the BAX/BCL2 ratio remarkably increased when the cell underwent combinational 
treatment (p<0.05).  
Conclusion: 5-Fluorouracil and Gamma Tocopherol reduced HT 29 cell proliferation. Our results suggest that 
combination therapy with 5- Fluorouracil and Gamma Tocopherol can be considered as a strategy for induction of 
apoptosis via increasing the BAX/BCL2 ratio. 
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Introduction 
It is well-established that cancer is the second cause 
of death following heart disease. Moreover, it is the 
third cause of death following accidents and heart 
disease in Iran (1). Specifically, colon cancer is the 
third most common cancer in the world and is the 
second and fourth most common cancer in Iran (2). 
Previous studies have demonstrated that the most 
important risk factors of colorectal cancer include 
aging, colorectal polyps, familial history of colon 
cancer, genetic disorders, inflammatory bowel 
disease, unsuitable diet, and smoking (3). Under 
normal conditions, there is a balance between 
programmed cell death (apoptosis) and cell 
viability, and disorders of these mechanisms can 
lead to cancer progression (4). Some drugs and 
materials are effective on the cell cycle and affect 
different pathways of these cell events. Among 
these agents, gamma-tocopherol (γT) as one of the 
eight isomers of vitamin E, has strong anti-cancer 
properties (5). This molecule is considered an 
effective anti-oxidant agent since it reduces reactive 
oxygen and nitrogen species, increases glutathione, 
and induces enzymes that break down and remove 
free radicals (6). Other anti-cancer properties of this 
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molecule include inhibition of lipoxygenase and 
cyclooxygenase enzymes, reduction of the 
isoprostane (one of the isomers of prostaglandin 
F2), and inhibition of tumor necrosis factor (TNFα) 
as an inflammatory agent, all of which mitigate 
inflammation and oxidative stress (7). Programmed 
cell death (PCD) occurs via external and internal 
(mitochondrial) pathways and is organized by 
BCL2 family genes (8). This family includes the 
anti-apoptotic genes B-cell lymphoma 2 (BCL2), B-
cell lymphoma-extra-large (BCL-X (L)), Myeloid 
leukemia cell differentiation protein (MCL1), as 
well as the pro-apoptotic genes BCL2 associated 
agonist of cell death (BAD), Bcl-2 homologous 
antagonist/killer (Bak) and Bcl-2-associated X 
protein (BAX) (9). The regulation of expression of 
these pro and anti-apoptotic proteins leads to the 
activity of apoptotic pathways; on the other hand, 
the pro-apoptotic and anti-apoptotic genes 
expression ratio determines the cell survival or 
apoptosis. Thus, there is a positive correlation 
between apoptosis and the effectiveness of 
chemotherapy (10). Gamma tocopherol induces 
expression of BAD, BAX, P21 (a cyclin-dependent 
kinase inhibitor), P53 (a tumor suppressor protein), 
and caspase 3 genes by increasing PPARα 
expression. Also, by reducing the mRNA level of 
the anti-apoptotic BCL2 gene, leads to cell death 
and stops the cell cycle by inhibiting cyclin-
dependent kinase (CDK) (11). 
According to the previous studies on different cell 
lines, BCL2 is known as an inhibitory factor of 
apoptosis and BAX is a key factor in the induction 
of cell death (12). In colon cancer, increasing BCL2 
expression decreases the BAX/BCL2 gene 
expression ratio leads to impaired apoptosis, as well 
as resistance to anticancer drugs and radiotherapy 
(13). This ratio within the cell regulates the cell's 
ability to respond to the apoptotic signal. In other 
words, the cells with a higher level of this ratio are 
more sensitive to apoptotic stimulators than cells 
with a lower ratio (14). In colon cancer treatment 
protocol, several drugs are used during 
chemotherapy and induce apoptosis. One of these 
drugs is 5-fluorouracil (5-FU), which is an analog 
of uracil and belongs to the antimetabolites family 
(15). This drug has severe side effects (16) and 
finding new treatment strategies can reduce its 
detrimental effects thereby increasing increase 
patient satisfaction. Combination therapy is one of 
the new strategies that minimize resistance to 
chemotherapy and reduces drug toxicity (17). 
In this study, we used gamma-tocopherol as an 
adjuvant in addition to the 5-fluorouracil to enhance 
the drug efficacy in stimulating apoptosis. For the 
first time, this work shows that the use of 5FU and 
gamma-tocopherol in combination therapy reduced 
cell proliferation and modified the BAX/BCL2 ratio 
in the Human Colorectal Adenocarcinoma Cell Line 
(HT29).  
Methods 
5-fluorouracil (5-FU), γ-tocopherol, Roswell Park 
Memorial Institute (RPMI) 1640 medium, 
streptomycin, glutamine, penicillin G, and RNA 
extraction kit (TRI Reagent) were purchased from 
Sigma-Aldrich (Germany). The human colon cancer 
cell line (HT-29) was procured from the National 
Cell Bank (Pasteur Institute, Iran). Fetal bovine 
serum (FBS) and PBS (Phosphate Buffered Saline) 
were obtained from GiBCo Invitrogen (USA). PCR 
Master Mix was purchased from Jena bioscience 
(Germany) and complementary DNA (cDNA) 
synthesis kit from Thermo Science (USA). The HT-
29 colon cancer cells were cultured in RPMI 
medium supplemented with 100 U/mL penicillin, 
10% FBS, 100 mg/mL streptomycin, at 37 °C 
incubators with 5% CO2. Cells were detached from 
the flask with 0.5 mL trypsin–EDTA (Ethylene 
Diamine Tetra Acetic acid) solution and passaged. 
Drug stocks (100 mM) were made with dissolving 
5-FU and γ-tocopherol in Dimethyl sulfoxide 
(DMSO) and different concentrations of drugs (5,10 
μM) were prepared via stock dilution in RPMI 1640 
medium (18). 
Cell Proliferation assay 
To assess proliferation and cell survival, the colony 
formation assay was carried out. It is essential to 
measure the proliferative capacity of treated cells to 
provide a measurement of cell death. This can be 
achieved using the colony-forming assay (CFA). 
Single tumorigenic cell with a high proliferation 
rate forms colonies in a few days. CFA monitors a 
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cancer cell's ability to produce a viable colony after 
treatment.  
Colon cancer cells were cultured in RPMI-1640 
medium and counted using a hemocytometer. These 
cells were seeded into a six-well culture plate 
containing RPMI 1640 medium (5×102 cells/well) 
and incubated at 37°C in 5% CO2. After 24 hours 
the cells were treated with different concentrations 
of drugs (10 μM 5-FU and 5 μM γ-tocopherol) in a 
single and combination pattern. One day later, the 
single-cell suspension was prepared by 
trypsinization. The cells were counted with a 
hemocytometer and incubated for additional seven 
days at 37° C. Then the medium was removed from 
each of the wells by aspiration. PBS was used for 
rinsing the cells. The colony fixation was carried 
out using sufficient 100% methanol to cover the 
cells for 15 minutes at room temperature. The cells 
were stained with sufficient crystal violet staining 
solution (0.01% (w/v)) to cover the cells for 5 
minutes at room temperature. Finally, an excess 
amount of fixator and dye was washed with dH2O 
and allowed the plate to dry. The colonies 
consisting of more than 50 cells were counted using 
an inverted microscope (19). The cells were 
evaluated morphologically and digital images of the 
colonies were analyzed using Image J software 
(Version 1.14). 
Quantitative real-time PCR analysis 
To evaluate of BAX/BCL2 ratio, the TRI Reagent 
kit and Revert Aid First Strand cDNA Synthesis Kit 
were used for RNA extraction and cDNA synthesis 
respectively, according to the manufacturer’s 
manual guide. Real-time Polymerase chain reaction 
(PCR) analysis was carried out using PCR Master 
Mix and β-actin as a reference gene (18). The 
reverse and forward primers sequences have been 
listed in table 1. Our results were evaluated as 
mean±standard deviation of three independent 
experiments. One-way ANOVA and t-test were 
performed to interpret the differences between 
control and treated groups. p< 0.05 was considered 
significant statistically. The data were analyzed 
with GraphPad Prism software (version 6.07). 
 
Table 1. Primers used for quantitative real-time PCR 
Primer sequence                                                       Target Gene   
 BCL2 (Gene ID: 596)                             Forward: 5′-CTTTAGAGTTGCTTTACGTTG-3′              
                                                                            Reverse: 5′-TCCATATTCATCACTTTGACAA-3′ 
           BAX (Gene ID: 581)                               Forward: 5′-TTCATGGACGGGTCCGGGGAGC-3  
                                                                            Reverse: 5′-TATCAGCCCATCTTCTTCCAGATGGT-3′ 
           β-actin (Gene ID: 60)                              Forward: 5’-CCTTCCTGGGCATGGAGTCCTG-3' 
                                                                            Reverse: 5’-GAAGATCAAGATCATTGCTCC-3'         
 
Results 
Determination of the inhibitory effect of 5-FU 
and γ-tocopherol on cancer cell death 
Macroscopic evaluation of colon cancer HT29 cells 
in single and combination-treated groups using 
crystal violet staining confirmed that 5-FU and γ-
tocopherol decreased the colony formation rate in 
cells (figure 1). As shown in table 2, it was 
demonstrated that 10 μM 5-FU and 5 μM γ-
tocopherol inhibited the number of colonies 
compared with the control group (500 cells/well 
and DMSO < 1%) (Table 2).  
This inhibition was more effective in cells treated 
with a combination of drugs. In other words, in the 
combination group, 10 μM 5-FU and 5 μM γ-
tocopherol, reduced the colony formation 
significantly (p < 0.05) (figure 2).  
Evaluation of 5-FU and γ-tocopherol 
combination therapy on BAX/BCL2 gene 
expression ratio 
To understand the role of 5-FU and γ‐tocopherol on 
BAX/BCL2 ratio in cancer cells, RT-PCR was 
performed. 10 µM 5FU and 5 µM γ‐tocopherol was 
used and the results were compared with untreated 
cells (500 cells/well and DMSO < 1%). Applying 5-
FU and γ‐tocopherol caused the dramatic 
enhancement of BAX/BCL2 ratio compared with 
the control group (p < 0.05). The most increasing 
effect belonged to the cells treated with a 
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combination of 5-FU and γ‐tocopherol (p < 0.01) (Figure 3). 
 
Figure 1. Colony-formation assay of HT29 cell line treated with 5-fluorouracil and γ‐tocopherol. Evaluation 
of cell survival in single and/or combination-treated groups carried out using colony formation assay. 
Macroscopic pictures of treated cells confirmed that 5-FU and γ-tocopherol decreased the colony formation 
rate in HT29 cells, especially in the combination group. 
 
  
Figure 2. Effect of 5-FU and γ-tocopherol on the colony 
formation in HT29 cell line - 10 μM 5-FU and 5 μM γ-
tocopherol decreased the number of colonies in treated cells 
(p<0.05) . Combination of drugs was more effective 
compared with single treatment (p<0.01). (n = 3). *p< 0.05, 
**p < 0.01. 
Figure 3. Effect of 5-FU and γ-tocopherol on BAX/BCL2 
ratio in HT29 cell line – Real-time PCR was performed to 
understand the role of 10 μM 5-FU and 5 μM γ‐tocopherol on 
this ratio. Findings showed that combination therapy caused 
BAX/BCL2 enhancement. The results were considered as the 
mean ± standard deviation (n = 3), *p< 0.05, **p< 0.01. 
 
Table 2. The mean number of colonies formed in the medium via treated cells with 5-FU and γ-T 
Mean colony number Concentration Treatment 
95 ± 5 No drug Control 
63 ± 4 Mµ10 5-fluorouracil * 
78 ± 3 Mµ5 γ-tocopherol * 
28 ± 2 M (γT)µ5    +( FU 5 )Mµ  10 5-FU + γ-tocopherol ** (Combination) 
The number of colonies was decreased in H29 cells treated with FU and γ-tocopherol and this effect was significant in 
the combination group. The results represent SD ± mean. (*p < 0.05 , ** p < 0.01)  
Discussion 
Cancer is a disease related to unusual cell growth 
with potency to spread to the other parts of the body 
(20). The invasive, difficult, costly, and non-
specific treatments, along with the growth of the 
number of patients with this disease have made 
cancer a major concern worldwide. One of the most 
common malignancies is colon cancer, which has a 
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high incidence rate in Iran due to lifestyle and 
cultural changes (21). 
5-Fluorouracil is one of the first-line treatments of 
colorectal cancer (22). Our findings revealed that 
this drug leads to cell death by reducing the 
expression of the BCL2 gene. Similar to our results, 
Yuwei et al. concluded that in colon cancer cell 
lines, treatment with 5FU (IC50:10.7-12.28 µM) 
would reduce the percentage of living cells 
dramatically (23-25). According to the colony 
formation test results, 5-FU reduced colony 
formation rate in HT29 cells, which was more 
effective in the combination of 5-FU and gamma-
tocopherol (Figure1). Consistent with these 
findings, Ofonime et al. showed that 0.1 µM 5-
fluorouracil decreased the colony formation of 
HT29 cells dose-dependently. Thus,  a 100 µM 
concentration of 5-FU eliminated the possibility of 
colony formation (26). In cancer cells, due to low 
tumor suppression factors, high expression of 
oncogenes, and high cell cycle speed, the ROS 
concentration is higher, and subsequently, 
autophagy and metastasis occur. All of these events 
lead to drug resistance (27). Several strategies have 
emerged to inhibit this phenomenon. One of the 
solutions is targeted therapy which prevents a wide 
range of side effects by directing the drug to the 
desired tumor tissue. Sabzichi et al. showed that the 
application of chemotherapy-based nanoparticles is 
a powerful method of drug delivery and enhances 
the effectiveness of drugs in the MCF7 breast 
cancer cell lines while also reducing its unpleasant 
side effects (28). Another most widely and effective 
strategy is combination therapy. The advantages 
attributed to combination chemotherapy include 
increasing patient satisfaction by reducing the 
frequency of drug administration, synergistic effects 
of agents, decreasing multidrug resistance, lowering 
the drug dose, and consequently reducing toxicity in 
healthy tissues (22). Banu & et al showed that 
combination therapy reduced the resistance to 
chemotherapy drugs and provided the opportunity 
to trigger multiple target routes simultaneously 
(24). Cancerous tissues have very complex 
characteristics and even one part of the tumor may 
have different behavior from the other part of the 
tumor in terms of response to treatment. In these 
cases, combination therapy leads to better results 
and prevents disease progression (29). 
In this study, we applied gamma-tocopherol as an 
adjuvant to boost the effectiveness of the main drug 
in the treatment of cancer cells and reduce its side 
effects. Similar to the results of our combined 
treatment study, Fu et al showed that 5-FU and 
Salinomycin had synergistic effects in liver cancer 
cell lines (17). Satari et al. also showed that Rutin 
along with 5 fluorouracil enhanced the effectiveness 
of 5-FU (26). We concluded that gamma-tocopherol 
enhances the inhibiting effects of 5-FU on the 
growth and proliferation of HT29 colon cancer 
cells. This isomer of vitamin E induces apoptosis by 
increasing dihydrosphingosine and 
dihydroceramide levels thereby increasing the 
activity of caspase 3 and 9 enzymes. It also inhibits 
leukotriene B4 (LTB4) and prostaglandin E2 
(PGE2) by inhibiting calcium channels causing 
induction of apoptosis as well as reduction of 
metastasis and angiogenesis (9). 
Although alpha-tocopherol is the predominant form 
of vitamin E in the blood, gamma-tocopherol is 
more important in preventing the progression of 
cancer due to its biological activities (4). HT-29 is a 
common colon cancer cell line with various 
characteristics such as secretion of pro-
inflammatory cytokines (TNFα, IL1, IL6), growth 
factors (TGF, EGF), and high cyclin D1 expression 
(30). Because of these properties, we used HT-29 
cells to examine the effect of gamma-tocopherol in 
increasing 5-fluorouracil-induced apoptosis by 
altering the BAX/BCL2 ratio. To study the 
mechanism by which gamma-tocopherol induces 
the apoptotic effects of 5-FU, the expression of 
genes affecting the apoptotic pathways was 
investigated. Low level of apoptosis is an important 
step in the progression of cancer (3). The 
mitochondrial pathway of apoptosis is very 
important and is switched by regulating the 
expression ratio of BAX and BCL2 apoptotic 
proteins (12). Thus, balance in the expression of 
these genes is essential for cell survival and death, 
where the elevation of the BAX/BCL2 ratio leads to 
caspase-3 activity, releasing cytochrome c from the 
mitochondria and activation of the internal 
apoptotic pathway (31).  
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Our results were consistent with Renault et al. 
regarding the increase in this ratio and its effect on 
cell death. They showed that increasing the ratio 
activated caspase-3 and resulted in cell death (32). 
Similarly, Hongwen et al. demonstrated that a high 
level of this ratio reduced the proliferation of 
prostate cancer cells (33).  
Any changes in the expression of these genes would 
indicate the degree of sensitivity of cells to 
apoptosis. In colon cancer, apoptosis plays an 
important role in the response to treatment, 
indicating a correlation between drug-induced 
apoptosis and treatment efficacy (10). Thus, the 
study of genes involved in mitochondrial apoptosis 
can be a predictor of resistance to chemotherapy 
drugs. Many studies have evaluated the function of 
BCL2 and BAX in colon cancer and other 
malignancies, indicating the role of these genes in 
cell survival and death (7).  
Our findings showed that in vitro treatment with 
5FU and gamma-tocopherol increased the 
BAX/BCL2 ratio. According to our results, the use 
of gamma-tocopherol in combination with 5-FU can 
be considered as a new strategy to boost the 
effectiveness of treatment in patients with colon 
cancer.  
Conclusion 
According to the results of the present study, a 
combination of 5-fluorouracil and gamma-
tocopherol inhibits cell proliferation and colony 
formation in HT29 colon cancer cells. 
Correspondingly, these agents reduce cell survival 
synergically by increasing the BAX/BCL2 ratio. 
This is more effective in cells treated with a 
combination of 5FU and gamma-tocopherol and 
leads to apoptosis in chemotherapy protocols. 
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